+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030 - Product Thumbnail Image

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030

  • Report
  • August 2019
  • 519 Pages
  • Global
From
Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 847 Pages
  • Global
From
Neuromyelitis Optica Spectrum Disorder - Opportunity Assessment and Forecast to 2030 - Product Thumbnail Image

Neuromyelitis Optica Spectrum Disorder - Opportunity Assessment and Forecast to 2030

  • Report
  • October 2021
  • 57 Pages
  • Global
From
Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • November 2022
  • 270 Pages
  • Global
From
Myasthenia Gravis Treatment - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 89 Pages
  • Global
From
RNAi Market: Therapeutics and Technologies by Key Therapeutic Areas, Route of Administration, Leading Industry Players, Type of RNAi Molecule and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

RNAi Market: Therapeutics and Technologies by Key Therapeutic Areas, Route of Administration, Leading Industry Players, Type of RNAi Molecule and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • May 2022
  • 467 Pages
  • Global
From
Microbiome Therapeutics: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) - Product Thumbnail Image

Microbiome Therapeutics: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Report
  • October 2022
  • 220 Pages
  • Global
From
Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035 - Product Thumbnail Image

Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

  • Report
  • September 2022
  • 799 Pages
  • Global
From
mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report by Type (Capping Agents, Nucleotides), Application (Vaccine Production, Therapeutics Production), End-use, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report by Type (Capping Agents, Nucleotides), Application (Vaccine Production, Therapeutics Production), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • June 2024
  • 120 Pages
  • Global
From
Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 77 Pages
  • Global
From
Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Thymectomy, Cholinesterase Inhibitors, Rapid Immunotherapies), By End-use (Hospitals, Clinics), By Region and Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Thymectomy, Cholinesterase Inhibitors, Rapid Immunotherapies), By End-use (Hospitals, Clinics), By Region and Segment Forecasts, 2023 - 2030

  • Report
  • October 2023
  • 120 Pages
  • Global
From
Rare Kidney Diseases Global Market Report 2024 - Product Thumbnail Image

Rare Kidney Diseases Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Myasthenia Gravis Treatment Market by Type, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Myasthenia Gravis Treatment Market by Type, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 196 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review - Product Thumbnail Image

Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review

  • Report
  • November 2024
  • Global
From
US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 - Product Thumbnail Image

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

  • Report
  • July 2023
  • 3600 Pages
  • United States
From
Synthetic Biology Market Report 2024-2034 - Product Thumbnail Image

Synthetic Biology Market Report 2024-2034

  • Report
  • July 2024
  • 402 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Diagnostic Test, Treatment - Global Forecast 2025-2030 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Diagnostic Test, Treatment - Global Forecast 2025-2030

  • Report
  • October 2024
  • 193 Pages
  • Global
From
Lysosomal Storage Diseases Market by Disease Type, Type of Therapy, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Lysosomal Storage Diseases Market by Disease Type, Type of Therapy, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1250 Pages
  • Global
From
Loading Indicator